Methyl 2-oxoindoline-7-carboxylate, 95.0%, 250mg

(S)-6-(4-CHLOROPHENYL)-N-(1-HYDROXYPROPAN-2-YL)-2-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE, 95%, 500mg

Bromomethyl methyl ether, 90.0%, 5g

3-Chlorobenzyl Alcohol>97.0%(GC)10mL

7-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride, 95.0%, 5g

Methyl 2-fluoro-5-(trifluoromethyl)benzoate, 99.0%, 5g

2-Tridecenoic Acid>80.0%(GC)5g

ethyl 6-methyl-4-phenyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 25g

ETHYL 1-CYCLOPROPYL-6,7-DIFLUORO-8-METHOXY-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLATE, 97.0%, 100g

Methyl 4-bromo-1H-indazole-3-carboxylate, 95.0%, 25g

(2-Oxoindolin-6-yl)boronic acid, 95.0%, 1g

4-Benzoylbutyric Acid>96.0%(GC)(T)25g

Système de vide série MD 4 MD 4C NT +2AK, 1 pièce